Karen Fernandez, MD, discusses the different types of treatment currently being tested for use in dry eye disease, which affects millions in the US.

The symptoms of dry eye are multifactorial, says Mina Massaro-Giordano, MD, making identifying and treating dry eye important ...

Viatris Inc. (NASDAQ:VTRS) saw its stock drop 3.6% following news that its late-stage trial for MR-139, a potential treatment ...

Viatris said on Friday that its experimental eye ointment failed to clear buildup or debris in the eyes in a late-stage study in patients with an inflammatory eye condition.

The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned. The items affected were shipped May 26, 2023 through April 21, 2025.

Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23.

Nearly 76,000 cases of eye care products – including eye drops sold nationwide – have been recalled by their manufacturer.

Artificial tears, eye drops, and eye care products from AvKare were recalled after the FDA found manufacturing violations. Here’s a list of recalled products.

Five different eye drop products that were sold between May 2023 and April 2025 were identified in a recall from manufacturer AvKARE.

The FDA and AvKare have reported a recall of eye care products, including drops and artificial tears, from BRS Analytical Service.

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision loss in mice with an inherited eye disease. In mice both with retinitis ...

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.